Clinical Trials List
Protocol NumberDBPR114-101
Active
2017-09-01 - 2020-09-01
Phase I
Terminated1
-
Trial Applicant
Efficient Pharma Management Corp.
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2026/04/01
Investigators and Locations
Principal Investigator
Co-Principal Investigator
- Shang-Yin Wu Division of Hematology & Oncology
- Jui-Hung Tsai Division of Hematology & Oncology
- Wu-Chou Su Division of Hematology & Oncology
- Shang-Hung Chen Division of Hematology & Oncology
- Chia-Jui Yen Division of Hematology & Oncology
- Yu-Min Yeh Division of Hematology & Oncology
- 黃盈慈 Division of Hematology & Oncology
- 蘇勇曄 Division of Hematology & Oncology
- Chun-Hui Lee Division of Hematology & Oncology
- 顏志傑 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Audit
None
Principal Investigator
Co-Principal Investigator
- Chi-Ching Chen Division of Hematology & Oncology
- Chang-Fang Chiu Division of Hematology & Oncology
- Ching Yun Hsieh Division of Hematology & Oncology
- 陳珈妤 Division of Hematology & Oncology
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
24 participants
-
Global
24 participants
